Shares of Somaxon Pharmaceuticals are currently trading above their 50-day moving average (MA) of $2.99 and should find resistance at their 200-day MA of $4.53. Look for the MA to provide support for a short-term pullback in the shares.
Somaxon Pharmaceuticals, Inc. is a specialty pharmaceutical company. The Company is focused on in-licensing, developing, and commercializing proprietary product candidates for the treatment of diseases and disorders in the fields of psychiatry and neurology.
SmarTrend expects the share price to pullback toward the $3.46 support level. Afterwards, we expect it to move upward with its peers in the SmarTrend Drug Manufacturers- Other industry.
No comments:
Post a Comment